Attention-Deficit Hyperactivity Disorder Market Forecast

Attention-Deficit Hyperactivity Disorder Market Forecast published by Datamonitor in July, 2009. This report price starts from US $ 15200.

Introduction

Abstract

Driven primarily by continued uptake of Shire' s market leading ADHD drug, Adderall XR (amphetamine extended release), seven major market ADHD revenues grew strongly at a compound annual growth rate (200408) of 13.5% to reach almost $4.4 billion in 2008. Ongoing uptake of Shire' s Vyvanse (lisdexamfetamine), was also a key contributor to market growth between 2007 and 2008.

• This report gives a strategic analysis of the likely impact that recent events will have on the future ADHD market.
• Includes sales forecasts for the key ADHD brands and generics as well as pipeline agents in the seven major markets to 2018.
• Quantify the current and future size of the seven major ADHD markets.

Table of Contents

OVERVIEW

• This product contains forecasts for attention-deficit hyperactivity disorder (ADHD) drugs across the seven major markets from 2009 to 2018. It has been designed for delivery in an excel data pack format.
  • The associated report can be found under Latest research in the Knowledge centre, through the search function or by contacting your sales representative.
  • Introduction
  • Scope of this research
  • Research and analysis highlights
  • Key reasons to read this report

• Forecasting Methodology
  • The forecasting model:
  • General event information:
  • Event selection and quantification:
  • Event parameters:

Related Reports